Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigoid Phleum pratense Immunotherapy for Grass Pollen Allergy
NCT00916422Phase 3Completed
- Sponsor
- LETI Pharma
- Start
- Jun 2008
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of depigoid phleum in seasonal allergic rhinitis (SAR), Rhinoconjunctivitis (RC), sponsored by LETI Pharma. Started Jun 2008; status: completed.
02
Drugs
depigoid phleum
03
Conditions
seasonal allergic rhinitis (SAR)Rhinoconjunctivitis (RC)
Beyond the preview
Go deeper on NCT00916422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916422.